Literature DB >> 16495559

Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection.

Nahed Ismail1, Heather L Stevenson, David H Walker.   

Abstract

Intraperitoneal (i.p.) infection with a high dose of a highly virulent Ehrlichia strain (IOE) results in a toxic shock-like syndrome characterized by severe liver injury and systemic overproduction of tumor necrosis factor alpha (TNF-alpha) by CD8+ T cells. We examined the role of TNF-alpha and TNF receptors in high-dose-IOE-induced shock/liver injury. TNF receptor (TNFR) I/II-/- mice lacking both the p55 and p75 receptors for this cytokine were more resistant to IOE-induced liver injury than their wild-type background controls. TNFR I/II-/- mice survived longer, dying between 15 and 18 days, with evidence of mild liver necrosis/apoptosis. In contrast, wild-type mice were not rescued from the lethal effect of IOE by TNF-alpha neutralization. TNF-alpha-depleted mice developed severe liver injury and succumbed to disease between days 9 and 11 postinfection, similar to sham-treated, infected wild-type mice. Although IFN-gamma production in the spleens of IOE-infected TNFR I/II-/- and TNF-alpha-depleted mice was higher than that detected in wild-type controls, these mice had higher bacterial burdens than infected controls. Following high-dose IOE challenge, TNFR I/II-/- and TNF-alpha-depleted mice have an early increase in IL-10 levels in sera and spleens, which was produced mainly by adherent spleen cells. In contrast, a late burst of interleukin-10 (IL-10) was observed in control mice. Nonadherent spleen cells were the major source of IL-10 in IOE-infected wild-type mice. We conclude that TNFR I/II and TNF-alpha participate in Ehrlichia-induced shock and host defense by regulating liver injury and controlling ehrlichial burden. Our data suggest that fatal ehrlichiosis could be a multistep process, where TNF-alpha is not solely responsible for mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495559      PMCID: PMC1418656          DOI: 10.1128/IAI.74.3.1846-1856.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  The role of nitric oxide in innate immunity.

Authors:  C Bogdan; M Röllinghoff; A Diefenbach
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 2.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 3.  Signaling by the TNF receptor superfamily and T cell homeostasis.

Authors:  K F Chan; M R Siegel; J M Lenardo
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

4.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  PCR amplification and phylogenetic analysis of groESL operon sequences from Ehrlichia ewingii and Ehrlichia muris.

Authors:  J W Sumner; G A Storch; R S Buller; A M Liddell; S L Stockham; Y Rikihisa; S Messenger; C D Paddock
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Proinflammatory effects of IL-10 during human endotoxemia.

Authors:  F N Lauw; D Pajkrt; C E Hack; M Kurimoto; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis.

Authors:  M E Martin; K Caspersen; J S Dumler
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

8.  Cutting edge: antilisterial activity of CD8+ T cells derived from TNF-deficient and TNF/perforin double-deficient mice.

Authors:  D W White; V P Badovinac; G Kollias; J T Harty
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.

Authors:  M Grell; E Douni; H Wajant; M Löhden; M Clauss; B Maxeiner; S Georgopoulos; W Lesslauer; G Kollias; K Pfizenmaier; P Scheurich
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

10.  Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta.

Authors:  R E Rojas; K N Balaji; A Subramanian; W H Boom
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

View more
  32 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

2.  Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells.

Authors:  Ulrike G Munderloh; David J Silverman; Katherine C MacNamara; Gilbert G Ahlstrand; Madhumouli Chatterjee; Gary M Winslow
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

3.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

Review 4.  The role of CD8 T lymphocytes in rickettsial infections.

Authors:  David H Walker; J Stephen Dumler
Journal:  Semin Immunopathol       Date:  2015-04-01       Impact factor: 9.623

Review 5.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

6.  Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae.

Authors:  Qin Yang; Heather L Stevenson; Melanie J Scott; Nahed Ismail
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

7.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  An animal model of a newly emerging human ehrlichiosis.

Authors:  Tais Berelli Saito; Nagaraja R Thirumalapura; Thomas R Shelite; Dedeke Rockx-Brouwer; Vsevolod L Popov; David H Walker
Journal:  J Infect Dis       Date:  2014-07-02       Impact factor: 5.226

9.  Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.

Authors:  Qin Yang; Purnima Ghose; Nahed Ismail
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis.

Authors:  H L Stevenson; E C Crossley; N Thirumalapura; D H Walker; N Ismail
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.